Search results
Results from the WOW.Com Content Network
Gastritis is the inflammation of the lining of the stomach. [1] It may occur as a short episode or may be of a long duration. [1] There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain (see dyspepsia). [1]
Weight loss is recommended for the overweight or obese, as well as avoidance of bedtime snacks or lying down immediately after meals (meals should occur at least 2–3 hours before bedtime), elevation of the head of the bed on 6-inch blocks, avoidance of smoking, and avoidance of tight clothing that increases pressure in the stomach.
A 2017 meta-analysis showed that the global per-person annual rates of recurrence, reinfection, and recrudescence is 4.3%, 3.1%, and 2.2% respectively. It is unclear what the main risk factors are. [184] Mounting evidence suggests H. pylori has an important role in protection from some diseases. [16]
This is a list of cities in Portugal. In Portugal , a city ( Portuguese : cidade ) is an honorific term given to locations that meet several criteria, such as having a minimum number of inhabitants good infrastructure (schools, medical care, cultural and sports facilities), or have a major historical importance.
Quinta da Regaleira [ˈkĩtɐ ðɐ ˈʁɨɣɐlɐjɾɐ] is a quinta (manor house) located near the historic centre of Sintra, Portugal.It is classified as a World Heritage Site by UNESCO within the "Cultural Landscape of Sintra".
In 1815, this resulted in Brazil being declared a co-kingdom with Portugal, raising it from its former colonial status. [12] This was an embodiment of Brazil's growing independence from Portugal, which intensified after the royal family's return to Europe in 1821. [10] [12]
António Luís Santos da Costa GCC GCIH (Portuguese: [ɐ̃ˈtɔnju ˈkɔʃtɐ]; born 17 July 1961) [3] is a Portuguese lawyer and politician who has served as President of the European Council since 2024.
Imeglimin (EMD- 387008,PXL- 008,RVT-1501, brand name Twymeeg) is an oral anti-diabetic medication. [1] [2] It was approved for use in Japan in June 2021.[3]It is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion.